|
Post by mssciguy on Dec 8, 2015 11:54:21 GMT -5
Double Downs take the lead 11/8 over Never Again and Drugs and Alcohol
What a race!
|
|
|
Post by BlueCat on Dec 8, 2015 11:59:46 GMT -5
Double Downs take the lead 11/8 over Never Again and Drugs and Alcohol What a race! ROTFL I'd assumed the double-downs were tanking up first before hitting the "Buy" button ….
|
|
|
Post by hankscorpio7 on Dec 8, 2015 12:02:30 GMT -5
Stick head in sand would have 100 votes by now.
|
|
|
Post by mssciguy on Dec 8, 2015 12:07:30 GMT -5
Going around the bend, it's Double Down with 12, followed by Never Again with 10 and Drugs and Alcohol with 9, Call Matt a distant fourth with 1.
Moving into the noon hour, traders conspiring over Manhattan cocktails...
|
|
|
Post by mssciguy on Dec 8, 2015 12:10:09 GMT -5
Lunchtime in Manhattan as Never Again is neck and neck with Double Down!!!
|
|
|
Post by mssciguy on Dec 8, 2015 12:20:56 GMT -5
DOUBLE DOWN overtakes NEVER AGAIN
the CROWD goes WILD
Wait... what's this...
|
|
|
Post by dudley on Dec 8, 2015 12:21:57 GMT -5
It's all a matter of perspective. You have to realize that Afrezza has only been on the market for 10 months. Yes, it is true that sales are nowhere near what we had all hoped for by this time, myself included. That is the ONLY aspect that for me has affected my investment comfort level. Sure, I wish I had waited to see the stock at these prices before buying but nothing else has changed for me. It's still a gigantic and growing market opportunity. Afrezza is still, by far, the best product available from both a convenience and performance standpoint. I do NOT believe Sanofi is walking away. They KNOW what a potential blockbuster Afrezza is, particularly with a label that allows them to broadcast all the benefits WE know Afrezza offers. Far better for them to stay the course and get the label changed (trials required to accomplish this, obviously) - which would allow devastatingly effective advertising, much better insurance coverage, and a clear and compelling reason for patients to use Affrezza. Documented superiority launches the product into the stratosphere. Walking away would mean they forego that blockbuster potential completely AND take a sizable writeoff. It's hard to see that happening, at least to me.
The manipulation has been going on essentially forever and the "catastrophe" can just as easily viewed as a stellar buying opportunity. 10 months - really just an introductory period for most new drugs and that includes Affrezza. I bought with a multi-year outlook and nothing at all has changed from that viewpoint. I haven't posted for months and it doesn't really matter - the chatter is the same. Most "investors" are so focused on the daily stock price they completely lose sight of the reasons they bought the stock in the first place. Sentiment and "news" articles are universally negative. Smelling like capitulation, blood in the streets, Armageddon. Usually a good time to buy.
|
|
|
Post by scottiemac on Dec 8, 2015 12:22:49 GMT -5
Where's "Sitting Tight and Ignoring the FUD"? That's me. I have never had investment drive me to drink, I'm not adding, and sure as hell not selling. One way or another I'm waiting it out.
|
|
|
Post by kball on Dec 8, 2015 12:26:26 GMT -5
Not digging the amusement level. Real pain
|
|
|
Post by mssciguy on Dec 8, 2015 12:28:57 GMT -5
dudley scottiemac yeah that's why I tried to use humor to vent a little. If we lined up PROS and CONS of Afrezza, the "slow rollout" is probably buried somewhere at the end of either column. It is amazing how emotional people can get, but on the other hand, it's that time of the year. Nice sunny day where I am at, just trying to have a little fun, but at the same time, it's very clear that the sentiment here is well-funded and probably buying the dip, at least a little. Happy holidays
|
|
|
Post by stevil on Dec 8, 2015 12:49:03 GMT -5
It's all a matter of perspective. You have to realize that Afrezza has only been on the market for 10 months. Yes, it is true that sales are nowhere near what we had all hoped for by this time, myself included. That is the ONLY aspect that for me has affected my investment comfort level. Sure, I wish I had waited to see the stock at these prices before buying but nothing else has changed for me. It's still a gigantic and growing market opportunity. Afrezza is still, by far, the best product available from both a convenience and performance standpoint. I do NOT believe Sanofi is walking away. They KNOW what a potential blockbuster Afrezza is, particularly with a label that allows them to broadcast all the benefits WE know Afrezza offers. Far better for them to stay the course and get the label changed (trials required to accomplish this, obviously) - which would allow devastatingly effective advertising, much better insurance coverage, and a clear and compelling reason for patients to use Affrezza. Documented superiority launches the product into the stratosphere. Walking away would mean they forego that blockbuster potential completely AND take a sizable writeoff. It's hard to see that happening, at least to me. The manipulation has been going on essentially forever and the "catastrophe" can just as easily viewed as a stellar buying opportunity. 10 months - really just an introductory period for most new drugs and that includes Affrezza. I bought with a multi-year outlook and nothing at all has changed from that viewpoint. I haven't posted for months and it doesn't really matter - the chatter is the same. Most "investors" are so focused on the daily stock price they completely lose sight of the reasons they bought the stock in the first place. Sentiment and "news" articles are universally negative. Smelling like capitulation, blood in the streets, Armageddon. Usually a good time to buy. I understand what you're saying, but this hasn't been the typical 10 month new drug that I have seen. Look up Butrans. When I worked in the pharmacy, we had a rep come in seemingly every other week asking us if we've seen any docs writing for it. We never did. We never even stocked it. Do some research on it. It's a very similar concept to Afrezza. It's a schedule 3 (controlled substance but can be phoned or faxed in with the added awesomeness of being able to have refills) transdermal patch. All others like it were schedule 2 (more restrictions) and were supposed to be more harmful. Butrans did the same thing as Duragesic patches, but were slightly safer since it's metabolized differently. Anyway, my point is, there was a novel drug (although ROA was the same) that should have been superior scientifically, but for whatever reason, never caught on. Like Butrans, what have we accomplished in 10 months? Yes, we're still young, but script counts aren't increasing, insurance isn't improving, and no road blocks are being removed. So really, we've only just wasted 10 months. Other drugs that succeed make progress during those 10 months. We've made none.
|
|
|
Post by silentknight on Dec 8, 2015 12:52:23 GMT -5
So much animosity today from some people. I actually find a little lighthearted commentary somewhat comforting. The stock is in the toilet. There's no reason people's attitudes should be too.
I am curious when the posters who love to throw out the "FUDster" description will begin to express any amount of concern for how things are going. I would think that as the stock approaches $1, even the rosiest of rose-colored glasses might need a cleaning or two.
I'm so far in the red, my morbid curiosity has me wondering just how far down this will go before anything of any significance is put forward by the players involved.
|
|
|
Post by thekindaguyiyam on Dec 8, 2015 12:53:27 GMT -5
stevil
nice to see that your no longer bleeding from your eyes in front of the cemetery and have now become the skeleton who is presumably buried. From "med student dude" to death. Nice transition; you must be taking your medical training seriously as it seems you are practicing on yourself.
|
|
|
Post by stevil on Dec 8, 2015 12:58:54 GMT -5
stevil nice to see that your no longer bleeding from your eyes in front of the cemetery and have now become the skeleton who is presumably buried. From "med student dude" to death. Nice transition; you must be taking your medical training seriously as it seems you are practicing on yourself. Glad you connected the dots between avatars. You're smarter than I thought . I haven't been giving you enough credit. If you're still around when I pay off my debt, I'll pitch in for charm school for ya. So don't go anywhere...
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Dec 8, 2015 13:01:02 GMT -5
I usually deal with it by ignoring threads like this.
|
|